Government Assertion of State Secrets Privilege in Private Party Litigation
Client Alert | 1 min read | 03.06.17
In a rare move, the Department of Justice intervened in Wever v. AECOM National Security Programs, Inc., asserting the state secrets privilege and requesting the dismissal of a $69 million dollar lawsuit between two private parties that it contends would risk the exposure of classified information if the suit were allowed to proceed. Although the Government was not an original party to the litigation, the Government argued in its Motion for Summary Judgment that the court is required to dismiss the case under the state secrets privilege because the Government, through the head of the department with control over the matter, after extensive consultation and coordination within and among relevant Executive Branch agencies, formally asserted the privilege and all three of the circumstances justifying dismissal exist: (1) the plaintiff cannot prove his or her claim without privileged evidence; (2) the defendants cannot properly defend the case without privileged evidence; and (3) further litigation would present an unjustifiable risk of disclosure.
Contacts
Insights
Client Alert | 2 min read | 11.14.25
Claim construction is a key stage of most patent litigations, where the court must decide the meaning of any disputed terms in the patent claims. Generally, claim terms are given their plain and ordinary meaning except under two circumstances: (1) when the patentee acts as its own lexicographer and sets out a definition for the term; and (2) when the patentee disavows the full scope of the term either in the specification or during prosecution. Thorner v. Sony Comput. Ent. Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012). The Federal Circuit’s recent decision in Aortic Innovations LLC v. Edwards Lifesciences Corp. highlights that patentees can act as their own lexicographers through consistent, interchangeable usage of terms across the specification, effectively defining terms by implication.
Client Alert | 6 min read | 11.14.25
Microplastics Update: Regulatory and Litigation Developments in 2025
Client Alert | 6 min read | 11.13.25

